Literature DB >> 30604506

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.

Aryeh Fischer1, Mary E Strek2, Vincent Cottin3, Paul F Dellaripa4, Elana J Bernstein5, Kevin K Brown6, Sonye K Danoff7, Oliver Distler8, Nik Hirani9, Kirk D Jones10, Dinesh Khanna11, Joyce S Lee1, David A Lynch6, Toby M Maher12, Ann B Millar13, Ganesh Raghu14, Richard M Silver15, Virginia D Steen16, Elizabeth R Volkmann17, Ronan H Mullan18, David N O'Dwyer11, Seamas C Donnelly18.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30604506     DOI： 10.1002/art.40769

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  8 in total

Review 1.  [Interstitial lung disease associated with connective tissue disease].

Authors:  Annette Fisseler-Eckhoff; Elisabeth Märker-Hermann
Journal:  Pathologe       Date:  2021-01-08       Impact factor: 1.011

Review 2.  Detection and classification of systemic sclerosis-related interstitial lung disease: a review.

Authors:  Daniel J DeMizio; Elana J Bernstein
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

3.  Treatment of systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials.

Authors:  David Roofeh; Oliver Distler; Yannick Allanore; Christopher P Denton; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2020-03-05

Review 4.  Systemic Scleroderma-Definition, Clinical Picture and Laboratory Diagnostics.

Authors:  Anna Kowalska-Kępczyńska
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.964

5.  Rituximab for interstitial pneumonia with autoimmune features at two medical centres.

Authors:  Kristin M D'Silva; Iazsmin Bauer Ventura; Marcy B Bolster; Flavia V Castelino; Amita Sharma; Brent P Little; Ayodeji Adegunsoye; Mary E Strek; Hyon Choi; Sydney B Montesi
Journal:  Rheumatol Adv Pract       Date:  2021-11-05

6.  Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases.

Authors:  Tobias Hoffmann; Peter Oelzner; Marcus Franz; Ulf Teichgräber; Diane Renz; Martin Förster; Joachim Böttcher; Claus Kroegel; P Christian Schulze; Gunter Wolf; Alexander Pfeil
Journal:  Arthritis Res Ther       Date:  2022-05-12       Impact factor: 5.606

Review 7.  An update on the pharmacotherapeutic options and treatment strategies for systemic sclerosis.

Authors:  Zsuzsanna H McMahan; Elizabeth R Volkmann
Journal:  Expert Opin Pharmacother       Date:  2020-07-17       Impact factor: 3.889

8.  [Treatment of lung fibrosis in systemic rheumatic diseases (new treatment)].

Authors:  Katharina Buschulte; Anna-Maria Hoffmann-Vold; Rucsan Dra Dobrota; Philipp Höger; Andreas Krause; Michael Kreuter
Journal:  Z Rheumatol       Date:  2021-09-10       Impact factor: 1.372
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.